U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807515) titled 'Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission' on Jan. 22.
Brief Summary: This is a single-centre, observational prospective study of cancer patients in remission administering FL Nourish capsules (FLNC), a proprietary Chinese Medicine herbal supplement, for the treatment of symptoms associated with qi deficiency and blood stasis syndrome.
Study Start Date: Feb. 10
Study Type: OBSERVATIONAL
Condition:
Cancer
Cancer Survivor
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Thong Chai Institute of Medical Research
Published by HT Digital Content Services with permission from ...